1. Sources and financial consequences of radical innovation: insights from pharmaceuticals;Sorescu;J Mark,2003
2. PhRMA. R&D Spending by U.S. Biopharmaceutical Companies Reaches Record $58.8 Billion in 2007 [press release]. March 24, 2008.
3. Rowberg RE. Pharmaceutical research and development: a description and analysis of the process. In: Parvis EN, ed. The Pharmaceutical Industry: Access and Outlook. New York: Nova Sciences Publishers, Inc.; 2002. p. 88–111.
4. The price of innovation: new estimates of drug development costs;DiMasi;J Health Econ,2003
5. IMS Health. IMS Health reports U.S. prescription sales grew 3.8% in 2007, to $286.5 billion [press release]. March 12, 2008.